Matches in SemOpenAlex for { <https://semopenalex.org/work/W3052885223> ?p ?o ?g. }
- W3052885223 endingPage "e21826" @default.
- W3052885223 startingPage "e21826" @default.
- W3052885223 abstract "Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is the primary treatment in treating with EGFR mutant nonsmall cell lung cancer (NSCLC). This systematic review and meta-analysis aimed to evaluate the efficacy and safety of the third-generation EGFR-TKI, osimertinib, and summarize the risk factors associating with outcome after osimertinib treatment.The Ovid Medline, Embase, Cochrane Library, and Pubmed were systematically searched due to December 10, 2019. All the studies that mentioned the overall survival (OS), progression-free survival (PFS), treatment response, and adverse events (AEs) of osimertinib were involved in our study. Hazard ratio (HR) with 95% confidence intervals was used for comparing OS and PFS.A total of 47 studies were included in the systematic review, of which 14 studies were used to compare the efficacy between osimertinib and other EGFR-TKI or chemotherapy. Patients treating with osimertinib favors a higher OS and PFS in all the patients (HR = 0.56 and 0.38, P < .001, respectively), and in subgroup analysis, compared with other treatments. Median 55% T790 mutant NSCLC patients might experience partial response, and 25% of patients remained as stable disease. The incidence of severe AE ranged from 0% to 5%, and the most common severe AE was pneumonia (3%). Patients with the T858R mutation may have a better OS than Del 19 mutation (HR = 0.55, P = .037), while patients who have a smoking history may have a higher risk of progression than never-smoker patients (HR = 1.47, P = .028).Osimertinib has an impressive antitumor activity compared with prior EGFR-TKI and chemotherapy with an acceptable response and tolerable AEs. EGFR mutation type and smoking status were the risk factors for mortality and progression in NSCLC patients." @default.
- W3052885223 created "2020-08-24" @default.
- W3052885223 creator A5035282947 @default.
- W3052885223 creator A5044243421 @default.
- W3052885223 creator A5064478014 @default.
- W3052885223 creator A5081338225 @default.
- W3052885223 creator A5090889478 @default.
- W3052885223 date "2020-08-21" @default.
- W3052885223 modified "2023-10-16" @default.
- W3052885223 title "The efficacy and safety of osimertinib in treating nonsmall cell lung cancer" @default.
- W3052885223 cites W1584059175 @default.
- W3052885223 cites W1840732701 @default.
- W3052885223 cites W1980497534 @default.
- W3052885223 cites W1983159571 @default.
- W3052885223 cites W1988729283 @default.
- W3052885223 cites W1992089244 @default.
- W3052885223 cites W2019607817 @default.
- W3052885223 cites W2054841768 @default.
- W3052885223 cites W2076178766 @default.
- W3052885223 cites W2088540000 @default.
- W3052885223 cites W2111662961 @default.
- W3052885223 cites W2116475791 @default.
- W3052885223 cites W2125665528 @default.
- W3052885223 cites W2135192471 @default.
- W3052885223 cites W2144330816 @default.
- W3052885223 cites W2146272590 @default.
- W3052885223 cites W2149733252 @default.
- W3052885223 cites W2154149901 @default.
- W3052885223 cites W2154662831 @default.
- W3052885223 cites W2156098321 @default.
- W3052885223 cites W2161959587 @default.
- W3052885223 cites W2235523093 @default.
- W3052885223 cites W2337507927 @default.
- W3052885223 cites W246286872 @default.
- W3052885223 cites W2520362701 @default.
- W3052885223 cites W2536396512 @default.
- W3052885223 cites W2560717039 @default.
- W3052885223 cites W2579565883 @default.
- W3052885223 cites W2591118779 @default.
- W3052885223 cites W2606658010 @default.
- W3052885223 cites W2611533960 @default.
- W3052885223 cites W2770828094 @default.
- W3052885223 cites W2773886054 @default.
- W3052885223 cites W2773942751 @default.
- W3052885223 cites W2790958665 @default.
- W3052885223 cites W2800339570 @default.
- W3052885223 cites W2800505416 @default.
- W3052885223 cites W2801531086 @default.
- W3052885223 cites W2803709151 @default.
- W3052885223 cites W2888522690 @default.
- W3052885223 cites W2888877308 @default.
- W3052885223 cites W2890155867 @default.
- W3052885223 cites W2891307631 @default.
- W3052885223 cites W2891728009 @default.
- W3052885223 cites W2893710996 @default.
- W3052885223 cites W2902378590 @default.
- W3052885223 cites W2903043657 @default.
- W3052885223 cites W2904882123 @default.
- W3052885223 cites W2909122839 @default.
- W3052885223 cites W2911174524 @default.
- W3052885223 cites W2912107322 @default.
- W3052885223 cites W2919185754 @default.
- W3052885223 cites W2921337959 @default.
- W3052885223 cites W2921710610 @default.
- W3052885223 cites W2925781938 @default.
- W3052885223 cites W2928309561 @default.
- W3052885223 cites W2939653476 @default.
- W3052885223 cites W2945297162 @default.
- W3052885223 cites W2947128784 @default.
- W3052885223 cites W2950167986 @default.
- W3052885223 cites W2953660906 @default.
- W3052885223 cites W2955028502 @default.
- W3052885223 cites W2962915882 @default.
- W3052885223 cites W2964236500 @default.
- W3052885223 cites W2969366720 @default.
- W3052885223 cites W2969577346 @default.
- W3052885223 cites W2969903907 @default.
- W3052885223 cites W2978192878 @default.
- W3052885223 cites W2982302612 @default.
- W3052885223 cites W2990041408 @default.
- W3052885223 cites W2994208520 @default.
- W3052885223 cites W2995864319 @default.
- W3052885223 cites W2999417355 @default.
- W3052885223 cites W4238604577 @default.
- W3052885223 cites W4294215472 @default.
- W3052885223 doi "https://doi.org/10.1097/md.0000000000021826" @default.
- W3052885223 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7447427" @default.
- W3052885223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32846826" @default.
- W3052885223 hasPublicationYear "2020" @default.
- W3052885223 type Work @default.
- W3052885223 sameAs 3052885223 @default.
- W3052885223 citedByCount "12" @default.
- W3052885223 countsByYear W30528852232021 @default.
- W3052885223 countsByYear W30528852232022 @default.
- W3052885223 countsByYear W30528852232023 @default.
- W3052885223 crossrefType "journal-article" @default.
- W3052885223 hasAuthorship W3052885223A5035282947 @default.
- W3052885223 hasAuthorship W3052885223A5044243421 @default.